A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT04888949 · COMPLETED
Trial details
- NCT number
- NCT04888949
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-15
- Primary completion
- 2023-05-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.